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Abstract A clear picture has emerged over the past years on
how a ‘classic’ mitochondrial protein, like subunit IV of
cytochrome c oxidase, might be targeted to mitochondria. The
targeting and subsequent import process involves the commit-
ment of the TOM (translocase in the outer mitochondrial
membrane) receptor complex on the mitochondrial surface, a
TIM (translocase in the inner mitochondrial membrane)
translocation complex in the mitochondrial inner membrane,
and assorted chaperones and processing enzymes within the
organelle. Recent work suggests that while very many mitochon-
drial precursor proteins might follow this basic targeting
pathway, a large number have further requirements if they are
to be successfully imported. These include ribosome-associated
factors and soluble factors in the cytosol, soluble factors in the
mitochondrial intermembrane space, an additional TIM translo-
case in the inner membrane and a range of narrow specificity
assembly factors in the inner membrane. This review is focused
on the targeting of proteins up to the stage at which they enter
the TOM complex in the outer membrane. ß 2000 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
In the yeast Saccharomyces cerevisiae, two-dimensional gels
resolve around 200^300 individual proteins (Lithgow, unpub-
lished data). Given that there will be some proteins present at
levels too low to be detected after electrophoresis, there might
be as many as 400^500 di¡erent polypeptides targeted to mi-
tochondria in this organism whose entire genome encodes
only 6000 or so proteins. Amongst the mitochondrial proteins,
eight are known to be encoded and synthesised within the
mitochondria itself, the rest are encoded on nuclear genes
and synthesised on ribosomes in the cytosol. Each one of
these polypeptides has its own biochemical identity and each
will require di¡erent degrees of assistance from the cellular
components that mediate protein targeting to mitochondria.
Using a few model substrates, a very clear picture of the
basic mitochondrial protein import pathway has been put
together (Fig. 1). For a ‘classic’ mitochondrial protein, like
subunit number IV of cytochrome c oxidase, a short prese-
quence at the amino terminal end of the newly synthesised
polypeptide contains the information required to commit the
protein to mitochondria. The presequences need only be
around 20 amino acids in length and able to form a basic,
amphipathic helix in order to ful¢l this function [1^3]. After
synthesis is complete, the precursor protein can be bound by
receptor subunits of the TOM complex (translocase in the
outer mitochondrial membrane) on the surface of the mito-
chondria, translocated through the outer membrane and
sorted, folded, processed and assembled into the correct sub-
mitochondrial compartment [4^6].
2. To fold or not to fold: the dilemma of every new polypeptide
2.1. Characteristics of some polypeptides targeted to
mitochondria
Since the presequence of CoxIV is clearly necessary and
su⁄cient for targeting, this and similar presequences have
been appended to various reporter proteins providing infor-
mation on the mechanics of the import pathway. The cyto-
solic enzyme dihydrofolate reductase (DHFR) has been a
common workhorse, since the tightly folded conformation
of DHFR can be stabilised with the substrate analogue me-
thotrexate. Since the addition of methotrexate to yeast cells
transformed to express mitochondrial-targeted DHFR fusions
prevents import, most and perhaps all of the molecules of
DHFR fusions must be imported after translation is com-
pleted in the cytosol [7].
However, it was always clear that some mitochondrial pre-
cursor proteins, while following the same pathway to the mi-
tochondria, would have more di⁄culty making the journey
than a DHFR fusion protein. Mitochondrial precursors
tend, by and large, to be more hydrophobic than polypeptides
that remain in the cytosol [8]. Many of them are integral
membrane proteins, or internal parts of multisubunit com-
plexes, that could not be expected to remain soluble. The in
vitro assays used to study protein import have been used to
demonstrate these features of mitochondrial proteins: prese-
quence DHFR can be synthesised and urea-denatured and
still be imported by isolated mitochondria [9], but the precur-
sor form of the hydrophobic ATPase subunit 9 is imported
poorly if at all after urea-denaturation of cytosolic extract
[10]. The precursor form of mammalian ornithine-transcarba-
mylase folds slowly [11] and import of the loosely folded
precursor into the mitochondrial matrix is rapid [12,13]. The
opposite is true of the precursor form of fumarase: domains
of this precursor fold rapidly and prevent import into isolated
mitochondria [14].
2.2. Molecular chaperones can assist import
post-translationally
For those mitochondrial precursors prone to misfolding or
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aggregation, cytosolic chaperones are available to prolong
their ‘import competence’ [15]. Cytosolic HSP70s interact
with a broad range, perhaps all, nascent polypeptides transi-
ently [16]. Interaction with polypeptides bound for mitochon-
dria might be exaggerated by the increased hydrophobicity of
the precursor polypeptides and the presence of the mitochon-
drial presequence: addition of puri¢ed HSP70 is su⁄cient to
stimulate the import of several precursor proteins in vitro [17^
20], and the depletion of HSP70 in vivo leads to the accumu-
lation of the precursor form of an ATPase subunit [21]. In the
case of aspartate amino-transferase, the presence of a prese-
quence in£uences the folding of precursor proteins to enable
HSP70 to recognise them as substrates [18].
Other chaperones can also promote post-translational im-
port by presenting a precursor in a conformation suitable for
binding to the TOM complex (an ‘import competent’ state).
The best characterised of these is MSF, a 14-3-3 protein, that
readily binds several mitochondrial precursor proteins, can
prevent and even reverse their aggregation, and directly trans-
fer precursors to the Tom70 and Tom37 subunits of the TOM
complex [22].
3. Mitochondrial protein import can start during translation
3.1. Kinetics of translation and translocation
Since on average there are only one or two molecules of
mRNA encoding a given mitochondrial precursor protein per
yeast cell [23], the rate and localisation of protein synthesis
has to be considered to understand all of the components that
can in£uence the protein import pathway. After export into
the cytoplasm, a mRNA will become translationally active
[24]. If the mRNA encodes a mitochondrial precursor protein,
that probably means that early passes of ribosomes will gen-
erate complete precursors that will encounter the mitochon-
drial surface post-translationally and might require assistance
from molecular chaperones in the cytosol. Given the dynamic
nature of the cytoplasm (including the mitochondria them-
selves), a stable mRNA^polysome complex will eventually
come into close proximity to the mitochondria, and once
one precursor has engaged the TOM complex on the mito-
chondrial surface, all subsequent precursors are likely to be
imported co-translationally (Fig. 2).
There is no evidence to support distinct co-translational and
post-translational protein import mechanisms. Rather, the
model presented in Fig. 2 suggests that the relative kinetics
of translation and import, as well as the stability of particular
mRNAs, might e¡ect the requirement for cytosolic factors
that assist either the folding or import of newly-translated
precursor polypeptides to mitochondria post-translationally.
Furthermore, it supports recent evidence that factors associ-
ated with active polysome complexes can assist protein import
co-translationally.
3.2. A co-translational phase can assist the import of some
precursor proteins
Using electron microscopy, Kellems et al. [25] demonstrated
that ribosomes accumulate on the surface of yeast mitochon-
dria. These ribosomes are translationally active and are pro-
grammed by mRNA encoding mitochondrial precursor pro-
teins [26,27]. According to the model presented in Fig. 2, these
represent polysome complexes in the later phase of transla-
tion.
Using a modi¢ed precursor protein that is imported post-
translationally with reduced e⁄ciency, Ellis and Reid [28]
screened for mitochondrial targeting suppressors. The gene
Fig. 2. Kinetic model linking translation and translocation of mito-
chondrial precursor proteins. A molecule of mRNA encoding any
given precursor protein is likely to initiate translation distant from
the mitochondrial surface, and in the early phase of translation pre-
cursor proteins will be complete before they encounter the TOM
complex on the mitochondrial surface (shown in red). Eventually,
short nascent chains are likely to encounter the mitochondrial sur-
face, and be recognised by the TOM complex. During the later
phase of translation, the precursor proteins synthesised would have
the opportunity to be imported co-translationally.
Fig. 1. Fundamental steps of protein import into mitochondria.
Most mitochondrial proteins are synthesised on cytosolic ribosomes,
many have an amino-terminal targeting sequence. After release from
the ribosome, the precursor protein can bind to the receptor sub-
units (37, 70, 20 and 22 represent the apparent sizes in kDa of the
Tom proteins) of the TOM complex. Multiple interactions of the
precursor with the channel subunits (Tom5, Tom22 and Tom40) ini-
tiates translocation of the precursor protein across the outer mem-
brane [4,40,52]. The ¢nal stage of translocation, and subsequent
processing and assembly of the imported protein, relies on compo-
nents of the TIM complexes and various soluble factors not shown
in this diagram. See the accompanying review by Koehler [6] for de-
tails.
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mutated in the mts1 cells they recovered encodes Npl3, an
mRNA-binding protein which shuttles mRNA out into the
cytoplasm [28^31]. The mts1 mutation was mapped to the
RNA-binding domain of Npl3 and found to result in an in-
creased residency of the mutant Npl3 protein throughout the
cytoplasm, increasing the stability of some mRNAs including
those encoding mitochondrial precursor proteins [32].
Using a multi-copy suppressor approach to cure a defect
based on minimal import of an exceptionally hydrophobic
precursor, the karyopherins Pse1p/Kap121p and Kap123p,
factors mediating the nucleo-cytoplasmic shuttling of proteins
like Npl3, were found to suppress mitochondrial protein im-
port defects [33]. One explanation for this exciting data is that
the karyopherins control levels of factors like Npl3 in the
cytoplasm, thereby stabilising some mRNAs and promote
co-translational protein import into mitochondria. This would
explain the increased import e⁄ciency of the hydrophobic
precursors: even for model precursors like DHFR fusion pro-
teins co-translational import can be an order of magnitude
more e⁄cient than post-translational import [34,35].
The precursor form of the Krebs cycle enzyme fumarase
provides another example of a precursor protein which can
be assisted into mitochondria co-translationally. In yeast, fu-
marase is found in both the cytosol and the mitochondrial
matrix. The structure of fumarase has been solved [36] and
the amino-terminal domain of fumarase appears to fold
tightly as molecules of the precursor leave the ribosome.
Those molecules interacting with the TOM complex post-
translationally cannot be successfully imported: after trans-
location of only a short segment of the precursor polypeptide,
the presequence is cleaved and the folded polypeptide falls
back out of the translocases and remains enzymatically active
in the cytosol. Only when import of the fumarase precursor is
assayed co-translationally is the polypeptide fully translocated
into the mitochondrial matrix [14].
One prediction that can be made from the kinetic model in
Fig. 2 is that components assisting in the co-translational
phase of protein import should be important in maintaining
the level of mitochondrial fumarase. The nascent polypeptide-
associated complex (NAC) is one such component. NAC was
originally identi¢ed in mammalian cell extracts as a ribosome-
associated factor that interacts with nascent polypeptides [37].
In yeast, disruption of either of the genes encoding the sub-
units of the NAC heterodimer leads to defects in protein
targeting to the mitochondria. In particular, the steady-state
level of fumarase is reduced at least three-fold in vegd1, vegd2
cells [38; George and Lithgow, in preparation].
A direct involvement of NAC in the co-translational import
of another mitochondrial precursor, malate dehydrogenase,
has been measured in an elegant in vitro assay [39]. The pre-
cursor was presented to isolated mitochondria as nascent
chain^ribosome complexes and e⁄cient import depended en-
tirely on the presence of NAC on the ribosomal surface: salt-
washing the nascent chain^ribosome complexes removes NAC
and prevents import of the precursor, re-addition of puri¢ed
NAC restores import. NAC could act on the nascent precur-
sor to ensure its presentation in an ‘import-competent’ con-
formation, but NAC might also assist the docking of ribo-
somes on the mitochondrial surface (Fig. 3).
4. The TOM complex: recognition, binding and translocation
4.1. Presequence recognition by the TOM complex
Whether the precursor protein has been released from the
ribosome or remains in the process of translation, an amino-
terminal targeting sequence will be able to interact with the
Fig. 3. Protein targeting and import into mitochondria. Most mitochondrial proteins are synthesised on cytosolic ribosomes and a large propor-
tion of the molecules synthesised from each mRNA will be completely translated before encountering a mitochondrion. Many of these polypep-
tides have chemical properties that promote binding of cytosolic factors, assisting their import by preventing aggregation, misfolding or proteol-
ysis. These import competent precursor molecules are recognised by receptor subunits of the TOM complex: these might always be part of the
translocase ‘holo-complex’, or dock to the ‘core-complex’ as depicted here [43,46]. Multiple interactions of the precursor with the channel sub-
units (Tom5, Tom22 and Tom40) initiate translocation of the precursor protein across the outer membrane [4,40,52]. The need for cytosolic
factors is obviated in the later stages of translation where the polysome complex can be close to the mitochondrial surface and precursor pro-
teins could be imported co-translationally. Factors such as NAC promote the import of ribosome-associated nascent chains [38,39].
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acidic receptor components of the TOM complex to initiate
translocation across the mitochondrial outer membrane [40].
There are six subunits in the TOM complex puri¢ed from
Neurospora crassa, eight in S. cerevisiae and seven in Solanum
tuberosum [41^43]. The acidic receptor subunits Tom20 and
Tom22 are highly conserved in fungi and animals and, though
they are speci¢cally modi¢ed in plants, they have probably
retained the function of presequence-binding throughout evo-
lution [44].
Tom20 and Tom22 bind exclusively to the amino-terminal
presequence of the ‘classic’ CoxIV precursor [45]. For precur-
sor proteins with ‘internal’ targeting sequences, like the ADP/
ATP carrier, the acidic receptors bind to short segments dis-
persed within the precursor [45] and it is likely that they also
bind the unusual carboxy-terminal signals in tail-anchored
proteins targeted to mitochondria. The additional receptor
subunits Tom37 and Tom70 interact with other parts of the
precursor, perhaps re£ecting an ability to take up unfolded
polypeptides from cytosolic chaperones like MSF [22].
4.2. Roving receptors, dynamic interactions and docking to the
core translocase complex
Interaction of the receptor subunits Tom20, Tom37 and
Tom70 with the rest of the TOM complex is somewhat labile
and can be disrupted during detergent solubilisation of the
complex from the outer mitochondrial membrane. Ahting et
al. [46] used this property of the complex to deliberately solu-
bilise a ‘core complex’, consisting of only Tom22, Tom40,
Tom6 and Tom7 from N. crassa mitochondria. The core com-
plex represents the translocation channel for protein import.
To be imported into mitochondria, nascent polypeptides are
threaded through a 20 Aî opening in the outer membrane
translocase [47], and electron microscopy of the detergent-
solubilised core complex shows a V20 Aî feature that accu-
mulates stain and is very likely to be the channel [43,46]. Since
the puri¢ed Tom40 subunit reconstituted into arti¢cial bi-
layers also displays electrophysiological properties of a V20
Aî channel, it is reasonable to conclude that Tom40 forms the
channel of the TOM complex through which a nascent poly-
peptide is threaded across the mitochondrial outer membrane
[48]. Indeed, Tom40 was ¢rst identi¢ed through cross-linking
to a CoxIV^DHFR fusion protein deliberately arrested to
span the outer membrane translocation site [49].
While the receptor subunits of the TOM complex can be
readily isolated from the core complex, there is good evidence
to suggest that in the intact membrane they interact with the
core complex and with each other. For example, Tom20 and
Tom22 work together to recognise and bind presequences [50]
and probably act together to recognise distinct features of the
presequence [45]. One possibility, represented in Fig. 3, is that
the Tom22 ‘receptor’ is only ever found in the core complex
with Tom40 and the tiny Toms, and represents the docking
point for the roving Tom20 receptor subunit. Also, Tom20
and Tom70 interact via their tetratricopeptide repeat domains
and precursors bound to Tom70 are imported poorly if at all
in yeast with a point mutation in the tetratricopeptide repeat
domain of Tom20, suggesting that Tom70 docks with Tom20
to feed precursors into the translocase channel [51].
5. Concluding remarks and future directions
We have come a long way towards understanding how pro-
teins are imported into mitochondria, but many aspects of the
process remain to be studied. The dynamic interactions be-
tween subunits of the TOM complex are likely to explain how
precursor molecules are translocated, but as yet no energy
input has been de¢ned for this process. High resolution struc-
tures will become available in the next years, but these repre-
sent the complex frozen in one conformation or another: how
does the complex move in order to achieve precursor recog-
nition, precursor binding, and then translocation? How does
the TOM complex recognise both the ‘classic’ basic, amphi-
pathic presequence and ‘atypical’ targeting sequences like
those found on proteins tip- or tail-anchored in the outer
membrane, the tiny TIMs (translocase in the inner mitochon-
drial membrane) in the intermembrane space and the various
inner membrane proteins that don’t have presequences? To
what extent do ribosome-associated factors like NAC, and
cytosolic chaperones like mitochondrial stimulating factor
(MSF), set-up and dictate the e⁄ciency of the overall import
process? Does a ribosome ever make intimate contact with the
TOM complex, or does each machine work oblivious to the
presence of the other? The answers to these questions promise
a comprehensive understanding of a most complicated biolog-
ical process.
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